John Michael Olichney, M.D. for UC Davis Health

John Michael Olichney, M.D.

Emeritus Professor, Department of Neurology

John Michael Olichney is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).




Behavioral Medicine

Cognitive Neuroscience



Locations and Contact

UC Davis Midtown Ambulatory Care Center

Midtown Neurology Clinic
3160 Folsom Blvd
Sacramento, CA 95816

Get Directions

Phone: 916-734-3588

Philosophy of Care

Dr. Olichney specializes in cognitive disorders and neurodegenerative diseases such as Alzheimer's disease. His philosophy is to provide individualized, comprehensive neurological care to each of his patients. His research interests include EEG, ERP and fMRI studies of language and memory, and clinical treatment trials for Alzheimer's disease.

Clinical Interests

John Olichney is a board-certified behavioral neurologist who specializes in diagnosis, treatment and study of memory and other cognitive disorders, and age-associated neurodegenerative diseases such as Alzheimer's disease. He is the clinical core director of the UC Davis Alzheimer's Disease Research Center (ADRC).

Research/Academic Interests

Dr. Olichney conducts research examining the mechanisms of language and memory using neuroimaging techniques. His laboratory is developing electrophysiological and neuroimaging techniques sensitive to the memory and language impairments that are characteristic of Alzheimer's disease and other neurodegenerative disorders.



Undergraduate School

B.A., UC Berkeley, Berkeley CA 1983

Medical School

M.D., UC Irvine College of Medicine, Irvine CA 1988


Internal Medicine, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu HI 1988-1989


Neurology, UC San Diego Medical Center, San Diego CA 1989-1992


Geriatric Neurology, San Diego Veterans Affairs, San Diego CA 1992-1994


Neuroscience, San Diego Veterans Affairs, San Dieto CA 1994-1995

NARSAD Young Investigator Award, 1997-1999, 2000, 2001, 2002, 2003

NIH Physician Scientist Award (National Institute on Aging), 1995, 1996, 1997, 1998, 1999, 2000, 2001

Honors in Neurology Research, 1987

Honors in Clinical Neurology Clerkship, 1987

Letter of Commendation for Outstanding Performance in Neuroanatomy, 1984

Li W, Kutas M, Gray JA, Hagerman RH, Olichney JM. The Role of Glutamate in Language and Language Disorders - Evidence from ERP and Pharmacologic Studies. Neurosci Biobehav Rev. 2020 Oct 9;119:217-241. doi:10.1016/j.neubiorev.2020.09.023. Epub ahead of print. PMID:33039453.

Mazaheri A, Segaert K, Olichney J, Yang JC, Niu YQ, Shapiro K, Bowman H. EEG oscillations during word processing predict MCI conversion to Alzheimer’s disease. Neuroimage: Clinical. 2017 Oct 9;17:188-197. doi:10.1016/j.nicl.2017.10.009. PMID:29159036.

Miller JW, Harvey DJ, Beckett LA, Green R, Farias ST, Reed BR, Olichney JM, Mungas DM, DeCarli C. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurol. 2015 Nov;72(11):1295-303. doi:10.1001/jamaneurol.2015.2115. PMID:26366714.

Yang JC, Niu YQ, Simon C, Chen L, Seritan A, Schneider A, Torabi Moghaddam S, Hagerman PJ, Hagerman RJ, Olichney JM. Memantine Effects on Verbal Memory in FXTAS: a Double-blind Brain Potential Study. Neuropsychopharmacology. 2014 Nov;39(12):2760-8. doi:10.1038/npp.2014.122. Epub 2014 May 29. PMID:24871547.

Zhang L, Sukharev D, Schneider A, Olichney JM, Seritan A, Hagerman RJ. Case report: Dystonia in a fragile X carrier. Mov Disord. 2014 Jun;29(7):E4-5. doi:10.1002/mds.23600. Epub 2011 Apr 5. PMID:21469199.

Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex. 2013 Nov;23(11):2657-66. doi:10.1093/cercor/bhs251. Epub 2012 Aug 23. PMID:22918986.

Farias ST, Mungas D, Reed B, Carmichael O, Beckett L, Harvey D, Olichney J, Simmons A, Decarli C. Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology. Neurobiol Aging. 2012 Aug;33(8):1758-68. doi:10.1016/j.neurobiolaging.2011.03.017. Epub 2011 May 4. PMID:21531482.

Yang J-C, Taylor JR, Chan S, Salmon DP, Iragui-Madoz V, Kutas M, Olichney JM. fMRI Congruous Word Repetition Effects Show Loss of Hemispheric Encoding/Retrieval Asymmetry in MCI. Presented at the 18th Annual Human Brain Mapping (OHBM), Bejing China. 2012 June. (abstract; ePub:

Zhang L, Pak J, Ortigas M, Olichney JM, Wheelock V, Frysinger R, Harrison M, Cornman E, Hagerman R. Case report: Deep brain stimulation of Vim improves FXTAS tremor and ataxia. Neurology. 2011;76:(suppl 4):A399. (abstract).

Kaur B, Harvey D, DeCarli C, Sabbagh M, Olichney JM. Measurable Parkinsonism in Clinically Diagnosed Alzheimer’s Disease: Associated with Mixed Neuropathologies. Neurology. 2011;76:(suupl 4):A622. (abstract).